Recovery of serum testosterone, LH and FSH levels following neoadjuvant-hormone cytoreduction and radical radiotherapy in localized prostate cancer

Clinical Oncology

Volumn 13, Issue 4, 2001, Pages 291-295

  Shahidi, M ^a   Norman, A R ^a   Gadd, J ^a   Huddart, R A ^a   Horwich, A ^a   Dearnaley, D P ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Follicle stimulating hormone; Leuteinizing hormone; Leuteinizing hormone releasing hormone analogues; Prostate cancer; Radiotherapy; Testosterone

Indexed keywords

CYPROTERONE ACETATE; FOLLITROPIN; GONADORELIN DERIVATIVE; GONADOTROPIN; GOSERELIN; LEUPRORELIN; LUTEINIZING HORMONE; TESTOSTERONE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFECT; EVALUATION; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; GONAD DYSFUNCTION; HORMONE DETERMINATION; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SHORT COURSE THERAPY; TESTOSTERONE BLOOD LEVEL;

EID: 0034866911     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.2001.9272     Document Type: Article

References (17)

1. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: A randomized comparative trial of the Radiation Therapy Oncology Group
2. Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer
3. A Phase III randomized trial to evaluate the efficacy of neoadjuvant therapy prior to curative radiotherapy in locally advanced prostate cancer patients
4. Leuprolide versus diethylstil-boestrol for metastatic prostatic cancer
5. Zoladex versus orchiectomy in treatment of advanced prostate cancer: A randomized trial
6. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: An approach toward the development of a male contraceptive
7. Intermittent androgen suppression in the treatment of prostate cancer: A preliminary report
8. Hormonal pattern and testicular histology in patients with prostatic cancer after long-term treatment with a gonadotropin-releasing hormone agonist analogue
9. Randomized comparative study of 3 vs 8 months of neoadjuvant hormonal therapy prior to radical prostatectomy: Biochemical and pathological effects
10. Histological and functional changes of the testis tissue during GnRH agonist treatment of prostatic cancer
11. Testicular histology after prolonged treatment with a gonadotropin-releasing hormone analogue
12. Leydig cell function and radiation: A review of the literature
13. Effects of fractionated irradiation on endocrine aspects of testicular function
14. Effects of external radiation therapy for cancer of the prostate on the serum concentrations of testosterone, follicle-stimulating hormone, luteinizing hormone and prolactin
15. The effects of external beam radiotherapy on endocrine function in patients with carcinoma of the prostate
16. Testicular doses in definitive radiation therapy for localized prostate cancer
17. Influence of radical prostatectomy on serum hormone levels